ZoBio

ZoBio is a company that provides gene to structure research services in early stage drug discovery. It specializes in enabling proteins for biophysical and structural biology studies and using biophysics to screen fragment libraries for selective ligands for a pharmaceutical target. The company also focuses on using both X-ray crystallography and NMR to provide 3D structural information on complexes of ligands bound to a protein and using medicinal chemistry expertise to advance fragment hits.